Related Experiment Videos
Defective ATM-p53-mediated apoptotic pathway in multiple sclerosis
Xinqing Deng1, Asa Ljunggren-Rose, Kevin Maas
1Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA. xinqing.deng@vanderbilt.edu
Annals of Neurology
|September 24, 2005
Summary
Multiple sclerosis (MS) patients exhibit impaired cell death regulation. Defects in the ATM-CHK2-p53 pathway prevent the elimination of autoreactive cells, potentially contributing to MS development and progression.
Area of Science:
- Immunology
- Cell Biology
- Neuroscience
Background:
- Defective elimination of autoreactive cells is implicated in autoimmune diseases like multiple sclerosis (MS).
- The ATM-CHK2-p53 signaling pathway is crucial for cellular responses to DNA damage and cell death.
- Understanding this pathway's role in MS is vital for disease mechanism insights.
Purpose of the Study:
- To investigate the activation and function of the ATM-CHK2-p53 pathway in peripheral blood mononuclear cells (PBMCs) from MS patients.
- To determine if defects in this pathway contribute to impaired cell death in MS.
Main Methods:
- Subjecting PBMCs from MS patients and healthy controls to gamma-irradiation.
- Analyzing the expression and activation of ATM, CHK2, and p53 proteins.
- Assessing cellular resistance to irradiation-induced apoptosis.
Main Results:
- A subset of MS patients displayed resistance to irradiation-induced cell death in their PBMCs.
- This resistance was linked to impaired constitutive expression and activation of ATM (ataxia telangiectasia mutated).
- Reduced ATM activation led to impaired p53 stabilization, hindering normal cell death processes.
Conclusions:
- Fundamental defects in ATM-CHK2-p53 pathway signaling exist in a subset of MS patients.
- These defects likely disrupt the regulation of immune cell populations in MS.
- Impaired cell death mechanisms may contribute to the development or progression of multiple sclerosis.